The top changes necessary in planning and designing pharma market access plans, including a revamp of the payer-value equation at pivotal points in the product life cycle.
Mel Walker
Advertisement
Managing Director, BioPharma Futures
Articles by Mel Walker
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Bob Mauch: Strengthening the Chain
2
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
3
Novo Nordisk Announces Major Shake Ups to Board
4
The Long-Term Outlook for MFN Pricing: Far-Reaching Issues and Considerations
5
